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ABSTRACT A clinical decision report appraising Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical 
and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. 
Cardiovascular and interventional radiology. 2008;31(1):73-85. https://doi.org/10.1007/s00270-007-9195-2 
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Clinical Context 
Diana Johnson (pseudonym), a 36 year-old G0P0 African American female with a history of uterine leiomyomas 
and Crohn’s disease, presented to the emergency department with acute worsening of chronic bilateral lower 
quadrant abdominal pain that radiated to the lower lumbar back. That morning, she awoke to severe “pressure” in 
her pelvic region with associated lightheadedness, abnormal vaginal bleeding, and urinary frequency. She 
appeared tearful and acutely distressed on presentation. This patient had been routinely following up with her 
obstetrics/gynecology clinic since the pain first began three years ago. CT scan had diagnosed an intramural 
uterine leiomyoma that was approximately 4.3 cm in size. While in the emergency department, the patient was 
given IV morphine 4 mg and IV ondansetron 4 mg, which helped resolve her pain. She underwent an additional CT 
scan to rule out perforation or rupture, which were not visualized. As this patient was a G0P0, she talked about her 
desire for future pregnancy. Knowing a hysterectomy would make this impossible, she asked about potential 
treatment options that could eliminate her pain without sacrificing her ability to carry a child. She was not 
interested in hormone therapy but had read about uterine artery embolization and myomectomy. She wondered if 
either option would jeopardize her fertility. If not, she wanted to know which option was better. 
Clinical Question 
Which treatment option for symptomatic leiomyomas—uterine artery embolization or myomectomy—confers least risk toward 
future pregnancy? 
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Research Article 
Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized 
controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and interventional radiology. 
2008;31(1):73-85. https://doi.org/10.1007/s00270-007-9195-2.  
Related Literature 
Information foraging began with an UpToDate search regarding “symptomatic leiomyomas.” Non-medical treatment options 
included hysterectomy, myomectomy, endometrial ablation, myolysis, uterine artery occlusion, and uterine artery embolization. 
Only myomectomy and uterine artery embolization were suggested for preservation of the uterus for pregnancy. There were two 
articles referenced for pregnancy results after myomectomy. The first was a case study that discussed a 35-year old woman who had 
an uncomplicated full term pregnancy after laparoscopic myomectomy.1 The second was a prospective observational study 
describing the pregnancy rate in 31 women who underwent laparoscopic myomectomy.2 Neither article had a large enough sample 
size to be considered for clinical use. In addition, there were no references regarding pregnancy outcomes in patients who had 
undergone uterine artery embolization. 
Further literature review continued with a PubMed search using the keywords “uterine artery embolization,” “myomectomy,” and 
“pregnancy[title].” This search returned 8 articles that discussed pregnancy outcomes after treatment of leiomyomas. Six of the 
articles solely explored pregnancy outcomes after uterine artery embolization.3-8 The remaining two manuscripts were reviews that 
compared uterine artery embolization to myomectomy.9,10 
Firouznia et. al followed 102 patients who underwent uterine artery embolization for symptomatic uterine fibroids, 23 of whom 
were seeking to become pregnant.3 Of the 23, 14 became pregnant for a total of 15 pregnancies. There were two miscarriages and 
13 full-term elective cesarean deliveries. The limited sample size precludes clinical utility. 
Pabon et. al conducted a prospective study at a city hospital in Spain to measure the number and course of pregnancy in 100 
patients who had undergone uterine fibroid embolization.4 Of the 100 patients, only eleven pregnancies were documented in 10 
women. There were 3 early miscarriages, 4 vaginal full-term births, and 4 full-term cesarean deliveries. Again, the limited sample 
size served of lower clinical utility. 
Ludwig et al. conducted a review focused on uterine fibroid embolization to compare it to the historically suggested myomectomy.5 
Publications were selected based on relevance of information to fertility and pregnancy without being limited to single case reports. 
The article had 52 references, of which 7 were randomized controlled trials. I reviewed each one to assess their ability to answer the 
clinical question. Two of the articles compared uterine artery embolization to hysterectomy, which was not an option for my 
patient.11,12 
Ultimately, the article chosen for critical review was a randomized controlled trial conducted by Mara et al.13 The group randomly 
selected a cohort of 121 patients with symptomatic leiomyomas who desired future pregnancy for either uterine artery 
embolization or myomectomy. Consistent follow-up with the patients revealed 50 gestations within the following two years. Based 
on the total number of pregnancies and labors as well as abortion rates, the study concluded that myomectomy has superior 
reproductive outcomes. In addition, due to the larger sample size, randomized set-up, extended follow-up period, and focus on both 
symptomatic relief and pregnancy outcomes, I decided to use this study to answer my clinical question. 
According to the SORT criteria, it meets Category B Grade of Recommendation based on few lower quality studies.14 
Critical Appraisal 
This research study is a prospective randomized controlled trial comparing symptomatic and reproductive outcomes in uterine 
artery embolization versus myomectomy in the treatment of uterine fibroids larger than 4 cm. According to the SORT criteria, it 
meets Level 1 evidence.14 
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Out of a group of 121 women, 58 received embolization while 63 underwent myomectomy. Their selection for each procedure was 
randomized by computer-generated code. There was minimal discussion of balance in baseline prognostic variables, so it is possible 
there were baseline differences between the two randomized groups. Inclusion criteria included (1) ultrasound-verified intramural 
fibroid of at least 4 cm, (2) age < 40 years, (3) serum FSH concentration <30 IU/L on the third day of menstrual cycle, and (4) planned 
pregnancy. 54% of the group were nulligravid, similar to my patient described above. Prior to the procedures, patients completed a 
questionnaire defining the intensity of six different myoma-related symptoms, which were compared to opinions afterwards. The 
subjectivity of these findings is less scientifically sound. 
All patients that were assigned to uterine artery embolization were treated by the same interventional radiologist. Trisacryl gelatin 
microspheres were used for embolization in all cases, and all patients were given the same regiment of pre-embolization antibiotics. 
All patients that were assigned to the myomectomy arm began with a hysteroscopy. Larger fibroids or unfavorable locations resulted 
in open myomectomies, while all other cases were performed by laparoscopy. The same two surgeons performed all of the 
surgeries. The level of training and expertise was not discussed for the interventional radiologist or surgeons. Outcomes could have 
differed depending on whether they were, for example, early attendings or attendings that had been in practice for decades. 
Patients followed up with the research group in 6-month intervals to document history of reproductive attempts. After 
embolization, 50% of patients became pregnant, 19% delivered, and 64% had a spontaneous abortion. After myomectomy, 78% of 
patients became pregnant, 48% delivered, and 23% had a spontaneous abortion. The differences were statistically significant. 
The study concluded that myomectomy is statistically superior in terms of reproductive outcomes. This was gauged based on the 
number of successful deliveries and the number of early pregnancy losses. The rate of spontaneous abortions after embolization was 
greater than 60% compared to 23% in the myomectomy group. Both procedures were deemed comparable in respect to technical 
success, frequency of complications, and relief of symptoms. 
The mean age of participants in the study was 32.4 in the embolectomy group and 32.0 in the myomectomy group. The results of 
the study may be less applicable to my patient, who is 36 years old, however, she still meets the inclusion criteria for the study, 
which required participants to be younger than 40. Another limitation is the lack of a control group. The study would benefit from 
including patients with symptomatic leiomyomas who attempt to become pregnant without any interventions. There was also no 
discussion of the difference in outcome between the patients who underwent laparoscopic myomectomy versus open 
myomectomy. These two groups were expressed together despite variances in invasion.  
Overall strengths include large sample size, uniformity in procedure, close follow-up with most patients, and the randomized, 
blinded approach. Each of these individually solidified the outcome as scientifically sound and replicable. 
Clinical Application 
Ms. Johnson wanted to know which treatment option for her leiomyoma would be better suited toward her desire 
to become pregnant. Based on the article presented, I advised her to opt for a myomectomy rather than a uterine 
artery embolization. The paper also discussed adverse outcomes of the procedures, of which all were relatively 
mild and transient. Myomectomy appears to be a safe solution to treating Ms. Johnson’s symptoms without 
jeopardizing her parity. However, it is also important that she regularly follow up with her physician to monitor for 
recurrence of the leiomyoma and to ensure a healthy gestation if she does become pregnant. 
New Knowledge Related to Clinical Decision Science 
Ms. Johnson’s concerns about the removal of her leiomyoma while maintaining her fertility led the treatment team to investigate 
which treatment would be recommended for her. As she initially presented both myomectomy and uterine artery embolization as 
options, these were the driving factors in our discussion and evidence search. If Ms. Johnson did not speak up, she might have 
received hormone therapy, or another methodology that she would not have been happy with. Instead, we were able to speak 
about the patient’s question and fear of permanent nulliparity. This clinical decision was driven by the severity of Ms. Johnson’s 
symptoms and her preferences. Often doctors need evidence to support the patient’s preferences. If there is documented danger, 
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we are obligated to share that as well with our patients. The strength of our reassurance or caution is a blend of clinical evidence 
and understanding the patient. 
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